Name of opportunity: 👀
Danaher Corp
The data: 🧾
Danaher, a diagnostics and life sciences corporation, has released its third quarter earnings today. Revenues at $5.8 billion were up 3% year on year, with non-GAAP core revenue also increasing, by 0.5%. Danaher reported profit of $1.71 per share, higher than estimates of $1.57. The company’s diagnostics segment sales came in at $2.36 billion, also higher than expected, and showing 5% growth in revenue since the year prior.
How hot is this investment opportunity? 🔥🔥🔥
Analysts predict the price of Danaher Corp. might increase from $263.15 to $272.11 in the next 12 months. If you invested $1000, you might profit $25.40. This fairly modest potential profit might make Danaher a good addition to your portfolio, especially if you are interested in investing in biotech companies.
While Danaher predicts a minor dip in revenue next quarter due to decreased spending on biotech, the fact that the Q3 earnings have shown some growth might be a good sign that the company’s sales will remain strong overall.
There are 15 different businesses under the Danaher umbrella, meaning that the company’s success will not be pinned upon one specific sector or industry. Danaher’s businesses fall under diagnostics, life sciences and biotech. The businesses make medical equipment, industrial filters, and specialist diagnostic tools, among other products. Danaher businesses also offer services such as end to end diagnosis solutions.
Cutting edge life sciences: 🔬
Danaher Corporation designs, manufactures and markets professional, medical, industrial, and commercial products and services. It was founded in 1984 and is headquartered in Washington DC. Danaher has been called one of the first American companies to operate under Kaizen philosophy, a set of principles laid out by Masaaki Imai, the famous Japanese business theorist and management consultant.
Which neme?: 🔍
Search directly for Danaher
Download Nemo to check out Danaher
